Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | UNK | Unknown | PO / MO |
The patient took Vivotif and ate a banana and did not take it completely in empty stomach.; Case reference number US-BN-2025-000875 is a spontaneous case initially received from a pharmacist via Communications (reference number: USBAV25-0927) on 25-Apr-2025 and concerns an adult female patient of unknown age. The patient's medical history and concomitant medications were not provided. On unspecified date, reported as probably three weeks ago, the patient took Vivotif (batch number: unknown) at unknown dose, orally for unknown indication. As reported, the patient took Vivotif and ate a banana and did not take it completely in empty stomach (explicitly coded as 'product administration error'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif. No further information was provided.; Reporter's Comments: This case concerned an adult female patient of unknown age. On an unspecified date, the patient took Vivotif vaccination, orally for unknown indication. As reported, the patient took Vivotif and ate a banana and did not take it completely in empty stomach which is considered as 'product administration error'. At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif. Product administration error is considered as listed as per company convention. The patients' medical history and concomitant medication details were not provided. Product administration error is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: This case concerned an adult female patient of unknown age. On an unspecified date, the patient took Vivotif vaccination, orally for unknown indication. As reported, the patient took Vivotif and ate a banana and did not take it completely in empty stomach which is considered as 'product administration error'. At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif. Product administration error is considered as listed as per company convention. The patients' medical history and concomitant medication details were not provided. Product administration error is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None